BioCentury
ARTICLE | Financial News

Elan gains on Athena Diagnostics sale

November 25, 2002 8:00 AM UTC

ELN was up $0.21 to $2.45 on 4.4 million shares on Monday. On Friday after market close, the company said it sold its 80% stake in subsidiary Athena Diagnostics to investment firm Behrman Capital for ...